Europe — EMA

Paclitaxel Cipla

Request sourcing

Pack/s

What is Paclitaxel?

Paclitaxel, the active ingredient in Paclitaxel Cipla, is a taxane presented as a sterile lyophilized powder for intravenous use. It is employed in the treatment of various solid tumours and is administered under the supervision of oncologists in hospital settings. GNH USA supplies Paclitaxel Cipla as a licensed, GDP‑compliant international pharmaceutical supplier serving oncology centres, hospitals and pharmacies worldwide.

GNH USA supplies Paclitaxel Cipla as a licensed, GDP‑compliant international pharmaceutical supplier serving oncology centres, hospitals and pharmacies worldwide.

What is Paclitaxel used for?

Paclitaxel is a chemotherapy agent that interferes with micro‑cellular .... - Breast cancer: Improves ... ... ... ... ... - ... .... ... - .... .... - .... - t

What are the side effects of Paclitaxel?

Common

Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.

Send a sourcing enquiry for this product →